Mimori T, Harigai M, Atsumi T, Fujii T, Kuwana M, Matsuno H, et al. Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan. Modern Rheumatology. 2017
http://dx.doi.org/10.1080/14397595.2016.1265695
When the above article was first published online, the images in figures 2 and 3 were transposed such that the image for figure 2 appeared with the caption for figure 3 and vice versa. Additionally, the article history information gave the received date as the 18th October 2016 and the accepted date as the 13th November 2016. Both of these dates were wrong.
The online version of this article has been corrected to display the images for figures 2 and 3 in their correct location. The article history dates have also been corrected.
Taylor & Francis apologises for these errors, which occurred through no fault of the authors.